MALIGNANT NEOPLASM OLIGOPROGRESSION

MALIGNANT NEOPLASM OLIGOPROGRESSION was reported 199 times

These drug classes are most commonly taken by patients reporting MALIGNANT NEOPLASM OLIGOPROGRESSION:

# Drug Count
0 Platinum-based Drug [EPC] 54
1 Folate Analog Metabolic Inhibitor [EPC] 25
2 Kinase Inhibitor [EPC] 22
3 Microtubule Inhibitor [EPC] 19
4 Programmed Death Receptor-1 Blocking Antibody [EPC] 19
5 Vascular Endothelial Growth Factor Inhibitor [EPC] 17
6 CTLA-4-directed Blocking Antibody [EPC] 14
7 Estrogen Receptor Antagonist [EPC] 12
8 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 7
9 RANK Ligand Inhibitor [EPC] 6
10 Nucleoside Metabolic Inhibitor [EPC] 5
11 Vitamin C [EPC] 5
12 Nonsteroidal Anti-inflammatory Drug [EPC] 4
13 Vitamin B12 [EPC] 4
14 Vitamin D [EPC] 4
15 Angiotensin Converting Enzyme Inhibitor [EPC] 3
16 Aromatase Inhibitor [EPC] 3
17 Corticosteroid [EPC] 3
18 HER2/neu Receptor Antagonist [EPC] 3
19 Platelet Aggregation Inhibitor [EPC] 3
20 Topoisomerase Inhibitor [EPC] 3
21 Alkylating Drug [EPC] 2
22 Atypical Antipsychotic [EPC] 2
23 Calcium Channel Blocker [EPC] 2
24 Dihydropyridine Calcium Channel Blocker [EPC] 2
25 HMG-CoA Reductase Inhibitor [EPC] 2
26 Leukocyte Growth Factor [EPC] 2
27 Programmed Death Ligand-1 Blocker [EPC] 2
28 Androgen Receptor Inhibitor [EPC] 1
29 Angiotensin 2 Receptor Blocker [EPC] 1
30 Benzodiazepine [EPC] 1
31 Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] 1
32 Dietary Cholesterol Absorption Inhibitor [EPC] 1
33 Factor Xa Inhibitor [EPC] 1
34 Nitrate Vasodilator [EPC] 1
35 Osmotic Laxative [EPC] 1
36 Proton Pump Inhibitor [EPC] 1
37 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
38 Sulfonylurea [EPC] 1
39 Xanthine Oxidase Inhibitor [EPC] 1